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Rapid eye movement (REM) sleep onset is triggered by disinhibition of cholinergic
neurons in the pons. During REM sleep, the brain exhibits prominent activity in the 5–
8 Hz (theta) frequency range. How REM sleep onset and theta waves are regulated
is poorly understood. Astrocytes, a non-neuronal cell type in the brain, respond to
cholinergic signals by elevating their intracellular Ca2+ concentration. The goal of this
study was to assess the sleep architecture of mice with attenuated IP3 mediated Ca2+
signaling in astrocytes. Vigilance states and cortical electroencephalograph power were
measured in wild type mice and mice with attenuated IP3/Ca2+ signaling. Attenuating
IP3/Ca2+ signaling specifically in astrocytes caused mice to spend more time in REM
sleep and enter this state more frequently during their inactive phase. These mice also
exhibited greater power in the theta frequency range. These data suggest a role for
astrocytic IP3/Ca2+ signaling in modulating REM sleep and the associated physiological
state of the cortex.
Keywords: EEG, mouse model, REM sleep, NREM sleep, sleep homeostasis, sleep deprivation, astrocyte, Ca2+
signaling
INTRODUCTION
The major aspects of sleep architecture are conserved from rodent to human. Each vigilance state:
rapid eye movement (REM) or paradoxical sleep, non-REM (NREM) sleep, and wake can be
distinguished by neuronal synchronization measured by electroencephalography (EEG) and the
level of movement detected by electromyography (EMG). During wake, the EEG is characterized by
low amplitude, desynchronized activity. The EEG shows increased synchrony during NREM sleep
and is dominated by slow wave activity (SWA) in the 0.5–4 Hz range. REM sleep is similar to wake,
with a desynchronized EEG but prominent hippocampal theta activity in the 5–8 Hz frequency
range (Platt and Riedel, 2011).
Upon natural transition into REM sleep, cholinergic projection neurons in the pons become
disinhibited and drive theta oscillations in the hippocampus (McCarley and Massaquoi, 1992;
Buzsàki, 2002; McCarley, 2007). Furthermore, experimental activation of pontine neurons using
optogenetics (Van Dort et al., 2015) or cholinergic agonists (Bezzi et al., 1998) increases time
spent in REM sleep. Interestingly, Hippocampal astrocytes express cholinergic receptors that elicit
calcium transients when stimulated (Shen and Yakel, 2012).
Intracellular Ca2+ transients in astrocytes mainly occur via release from internal stores upon
activation of the inositol triphosphate receptor 2 (IP3R2). The extent to which these Ca2+ signals
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provide physiological output is a major focus of current research
and is incompletely understood (Khakh and McCarthy, 2015).
Genetic deletion of IP3R2 does not alter homosynaptic plasticity
(Bonder and McCarthy, 2014; Petravicz et al., 2014); however,
these Ca2+ stores contribute to heterosynaptic, cholinergic-
mediated plasticity and performance in the Morris water maze
(Takata et al., 2011).
We have previously demonstrated that SNARE-mediated
release of gliotransmitters from astrocytes is necessary for
sleep homeostasis (Halassa et al., 2009; Schmitt et al.,
2012). Considering that Ca2+ signaling is required for
neurotransmission, and that there is extensive evidence
that it is required for gliotransmission (Porter and McCarthy,
1997; Araque et al., 1998; Buzsàki, 2002; Hua et al., 2004; Kreft
et al., 2004; Chen et al., 2005; Pryazhnikov and Khiroug, 2008;
Paukert et al., 2014), we asked whether we could replicate the
dnSNARE phenotype of impaired sleep homeostasis in a mouse
model of disrupted astrocytic IP3/Ca2+ signaling.
We overexpressed a venus tagged IP3 5’phosphatase (VIPP)
transgene selectively in astrocytes to enhance the metabolism
of IP3 to IP2 and attenuate IP3-mediated Ca2+ signaling
in astrocytes. We found that VIPP expressing mice had
increased REM sleep and theta power, suggesting a previously
unrecognized and unique role for astrocytic IP3/Ca2+ signaling
in neuromodulation. Moreover, these results demonstrate the
importance of the astrocyte, a glial cell sub-type, in the control
of the generation of sleep states and brain rhythms.
MATERIALS AND METHODS
Animals
All procedures were in strict accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals and were approved by Tufts University and Institutional
Animal Care and Use Committees. All animals were housed on a
12 h light/dark cycle and were given standard chow and water ad
libitum.
The VIPP mouse line was created by fusing the type
I Ins(1,4,5)P3 5′-phosphatase (IPP) construct to the Venus
construct and co-expressing the Lac-Z reporter (De Smedt et al.,
1997). The original IPP construct in pcDNA3 (De Smedt et al.,
1997) was released by BamHI/XbaI digestion and cloned into
pUC19 cloning vector. The coding region of Venus (Evanko and
Haydon, 2005) was PCR amplified, digested with BamHI/NcoI,
and ligated in-frame into the corresponding sites of IPP in
pUC19. For experiments involving cultured astrocytes, the VIPP
fragment was cloned into the expression vector pcDNA3.1. To
make the tetO-transgenic vector, the VIPP fragment was excised
from pcDNA3.1 using BamHI (blunted)/XbaI, and the ligated
into StyI (blunted)/SpeI digested pTg1-tetO vector. The pTg1-
tetO-plasmid has been described elsewhere (Pascual et al., 2005).
TetO-VIPP and tetO-LacZ were digested to remove bacterial
sequences and co-injected into C57BL/6J fertilized zygotes.
Founders were identified by PCR, and subsequently crossed
with GFAP-tTA animals (Pascual et al., 2005). All breedings
were performed with 40 mg/kg doxycycline (Dox, Bioserv,
Frenchtown, NJ, USA) in the food, and offspring were maintained
on Dox until weaning to suppress transgene expression during
embryonic life and post-natal development. VIPP or littermate
control C57BL/6J mice were used.
Slice Preparation
Horizontal hippocampal slices (300–330 µm) from 6 to 10-
week-old mice were prepared as described previously (Pascual
et al., 2005). Briefly, the brain was rapidly removed and
chilled with cold (4◦C) artificial cerebrospinal fluid (ACSF)
of the following composition (in mM): 124 NaCl, 3.1 KCl,
2 MgCl2, 1 CaCl2, 26 NaHCO3, 1 NaH2PO4, 10 glucose,
1 Na-pyruvate, and 0.6 ascorbic acid (pH 7.4 adjusted with
95% O2, 5% CO2) or 85 NaCl, 2.5 KCl, 1.25 NaH2PO4,
0.5 CaCl2, 4 MgCl2, 25 NaHCO3, 75 sucrose, 25 glucose,
and 0.5 ascorbic acid (pH 7.4 with 95% O2, 5% CO2).
The brain was then cut with a Leica VT 1000S vibratome
and CA3 to CA1 connections were severed. Slices were
incubated at 30–32◦C for 1 h recovery and were recorded at
32–34◦C.
Ca2+ Imaging in Brain Slices
A multicell bolus loading was performed as previously described
(Li et al., 2003). Rhod-2/AM, was dissolved in 20% pluronic
acid in DMSO to yield a concentration of 20 mM. For cell
loading, this solution was diluted 1/100 with an injection solution
containing (in mM) 150 NaCl, 2.5 KCl, 10 HEPES, pH 7.4. An
injection pipette (1–2 M) was filled with this solution and
inserted into stratum radiatum of CA1 region, and ejected using
positive pressure (1 min, 70 kPa; Picospritzer NPI, Germany).
One hour later images were acquired using a Q-imaging cooled
CCD camera and ImagePro software.
Slice Stimulation
Wild type and VIPP brain slices were isolated and responses
to stimulation were quantified as delta fluorescence, expressed
as 1F/F = (F1−F0)/F0, where F0 and F1 are the value of
the fluorescence in the ROI at rest and the given time point,
respectively. Slices were stimulated with either 100 µM ATP
application or electrical stimulation of the Schaffer collateral
fibers. Stimulation pulses were elicited using a 125 µm concentric
Pt-Ir electrode. Either 1 s of 100 Hz or five theta burst trains were
used to stimulate slices. Theta burst stimulation was 100 Hz for
40 ms with 200 ms intervals. Recordings of astrocyte responses to
stimulation were made in area CA1.
Astrocyte Culture, Transfection, and
Ca2+ Imaging
Cortical astrocyte cultures were prepared from 1 to 2-day-old
mice. Cells were grown in modified Eagle’s medium containing
10% fetal bovine serum, 2 mM L-glutamine, 40 mM D-
glucose, 14 mM sodium bicarbonate, 1% sodium pyruvate,
and 1% penicillin/streptomycin in 95% air/5% humidified CO2.
Confluent cultures were shaken overnight followed by a media
change and a subsequent round of shaking. After the final
shaking, adherent cells were dissociated using 0.25% trypsin and
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1 mM EDTA, and replated on glass coverslips. Cells were used
after 2–4 days in culture.
Astrocytes were transfected using Fugene (Roche,
Indianapolis, IN, USA) and 24–72 h post-transfection, astrocytes
cotransfected with IPP and DsRed were loaded with Fluo-4 by
incubation in Fluo-4/AM, and Ca2+ imaging was performed on
the stage of an inverted microscope. Astrocytes transfected with
VIPP were loaded with Rhod-2 by incubation in Rhod-2/AM and
Ca2+ imaging was performed in a similar fashion. Ins(1,4,5)P3
5′-phosphatase activity at 1 µM substrate level was performed on
VIPP transfected COS-7 cells as described previously (Terunuma
et al., 2008).
Surgery
Mice aged 8–12 weeks were anesthetized with isoflurane and
placed into a stereotaxic frame. Electroencephalogram (EEG)
head implants (Pinnacle Technology, Inc.) were placed as
previously described (Clasadonte et al., 2014). After surgery, mice
were subcutaneously injected with buprenorphine (0.08 mg/kg)
and lactated Ringer’s solution, and fed moistened rodent food.
After 5 days of postoperative recovery, lightweight recording
cables were connected to the head implants and mice were
placed in Circular Plexiglas cages (Pinnacle Technology, Inc.) and
acclimated for a week.
Data Acquisition
Electroencephalography/electromyography activity was
continuously monitored for 48 h. EEG/EMG activity starting
at Zeitgeber time (ZT) 0 was measured for 24 h (baseline),
followed by 6 h of sleep deprivation enforced by gentle handling.
EEG/EMG activity was monitored during the 6 h of sleep
deprivation and 18 h of recovery sleep. During data acquisition,
EEG signals were high pass filtered at 0.5 Hz and low pass
filtered at 40 Hz. EMG signals were high pass filtered at 0.5 Hz
and low pass filtered at 100 Hz. The amplifier system (Pinnacle
Technology, Inc.), sampled at 250 Hz with a PAL 8400 data
acquisition system (Pinnacle Technology, Inc.).
Vigilance State Scoring and Analysis
Sleep stages were scored visually based on 4 s epochs by
a trained experimenter using SleepSign for Animal software
(Kissei Comtec). Wakefulness consisted of low-amplitude, high-
frequency EEG, and high EMG activity; REM sleep consisted of
low-amplitude EEG activity with prominent 5–8 Hz frequency
and low EMG activity; NREM sleep consisted of high-amplitude,
low-frequency EEG with little EMG modulation. Time spent in
each state was expressed as a percentage of the total recording
time in 1 h time bins. EEG power spectra of consecutive 4 s
epochs [fast Fourier transform (FFT) routine; Hanning window]
were calculated. The EEG power during NREM sleep from 0.5 to
1.5 Hz was defined as low frequency slow wave activity (lf-SWA)
and was used as a quantitative measure of sleep pressure and
homeostatic sleep drive (Franken et al., 2001; Cirelli et al., 2005).
The EEG power of lf-SWA during NREM sleep was used to assess
hour-by-hour sleep power. Hour by hour lf-SWA was normalized
to the last 4 h of the baseline day. The EEG power from 5.0 to
8.0 Hz was defined as theta activity and was used as a measure of
theta power. To compare theta power across genotypes, raw data
were normalized to 0.5 to 1.5 Hz frequency range. Normalization
in this range was chosen because it best represented the raw data
and there were no differences in power between wild type and
VIPP mice in this frequency range.
Tissue Processing and
Immunohistochemistry
Eight to ten week old animals were cardiac perfused with
phosphate buffered saline (PBS) and paraformaldehyde (PFA).
The brain was extracted, post-fixed in PFA for 1 h at 4◦C, placed
overnight in 30% sucrose and frozen at −80◦C. Coronal sections
(40 µm) were cut, washed with PBS, and permeabilized with
0.1% Triton X-100, 5% horse or goat serum in PBS. Unless
otherwise indicated the antibodies used were from Millipore,
Temecula, CA, USA. We used mouse NeuN antibody, 1:1000,
rabbit NG2 antibody, 1:1000, rabbit GFAP antibody (Sigma,
St. Louis, MO, USA), 1:1000, and rabbit Iba1 antibody (Wako
Chemicals, Richmond, VA, USA), 1:500. Secondary antibodies
conjugated to either Alexa 633 or 568 were used. Sections
were mounted and visualized on either Fluoview 1000 confocal
microscope (Olympus, Center Valley, PA, USA) or A1 confocal
microscope (Nikon, Tokyo, Japan). Venus fluorescence was
detected at 515 nm.
Statistics
For all experiments except sleep studies, comparisons between
two groups were conducted with Student’s t-test. For sleep
studies, comparisons between two groups were made using a
Mann–Whitney U test. Groups with multiple data points were
compared using two-way repeated measures ANOVA, followed
by a Tukey’s post hoc multiple-comparisons test. Statistical
significance was defined as p < 0.05. Data are presented as
mean± SEM unless otherwise stated.
RESULTS
Astrocyte-Selective Expression of VIPP
Attenuates Astrocytic Ca2+ Signals
To determine the importance of astrocytic IP3/Ca2+ signals, we
used molecular genetics to selectively impair IP3/Ca2+ signaling
in astrocytes. IP3 is metabolized through type I Ins(1,4,5)P3 5′-
phosphatase (IPP) activity (De Smedt et al., 1997). We transiently
transfected cultured astrocytes to express IPP and demonstrate
that it attenuates agonist-induced Ca2+ signaling in these cells
(Supplementary Figure S1A; 83 ± 2% reduction of the Ca2+
signal, n = 10 coverslips). To generate a fluorescent variant of
IPP for use in transgenic animals, we tagged the N-terminal of
IPP with the YFP variant Venus. Transient transfection and over
expression of Venus-IPP fusion protein (VIPP) attenuated Ca2+
signaling in cultured astrocytes (Supplementary Figure S1B;
67 ± 3% reduction of the Ca2+ signal, n = 6 coverslips). When
the transgenic vector was transfected into COS-7 cells, anti-GFP
blotting of protein lysates revealed a band corresponding to the
predicted size of the Venus-IPP fusion protein (Supplementary
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Figure S1C), and biochemical analysis showed a 40-fold increase
in IPP activity (Supplementary Figure S1D).
We generated astrocyte-specific transgenic animals using the
Tet-Off system (Figure 1A) (Pascual et al., 2005; Halassa et al.,
2009) to allow conditional expression of VIPP in astrocytes
(VIPP mice). TetO.VIPP and tetO.β-gal were co-injected into
C57BL/6J fertilized zygotes to generate tetO.VIPP founder lines,
which were screened for transgene expression by being crossed
with GFAP.tTA mice (Figure 1A) (Pascual et al., 2005; Halassa
et al., 2009). Bigenic offspring of one line showed abundant
Venus fluorescence when examined by confocal microscopy
(Figures 1B–H). Double-labeling experiments demonstrated that
FIGURE 1 | Astrocyte-specific expression of venus tagged IP3 5′phosphatase (VIPP) attenuates Ca2+ signaling in hippocampal CA1 astrocytes.
(A) Cartoon depicting the GFAP promoter driving the expression of VIPP and β-gal. (B,C) Top view confocal images (20× 0.7NA objective) of hippocampal
CA1-region showing VIPP expression and CA1 neurons (NeuN) and astrocytes (GFAP). (D–H) High magnification single confocal planes (60× 1.4NA objective)
showing VIPP colocalizes with GFAP (D), but not with NG2 (E), Olig1 (F) Iba1 (G) or NeuN (H). (I) Quantification of D–H. n = 6 animals for each staining. (J,K)
Astrocytic Ca2+ responses in response to 100 µM ATP (J,K), five theta trains (L,M) or 100 Hz, 1 s tetanic stimulation (N,O) are significantly attenuated by
expression of VIPP (green). Quantitation (K,M,O) is shown as the integral of 1F/F0 signal for 2 min after ATP application (t-test, ∗p < 0.0016 in K; p < 0.025 in M;
p < 0.006 in O), for 3 min after theta burst stimulation and 3 min following tetanic stimulation of the Schaffer collaterals. Number of tested cells and tested slices (in
parenthesis) are indicated.
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FIGURE 2 | Astrocytic VIPP expression increases time spent in rapid eye movement (REM) sleep and decreases time spent in wake. (A) Percent
recording time spent in wakefulness. VIPP mice spent significantly less time awake during ZT 6-12 (left: ∗p < 0.05, two-way RM ANOVA; right: ∗p < 0.05,
Mann–Whitney U test). (B) Percent recording time spent in NREM sleep. Astrocytic VIPP and wild type mice spent the same amount of time in NREM sleep (two-way
RM ANOVA: n.s.). (C) Percent recording time spent in REM sleep. VIPP mice spent significantly more time in REM sleep during the second half of the light cycle and
the second half of the dark cycle (left: ∗∗p < 0.01, two-way RM ANOVA, ZT9: Tukey’s post hoc test: p < 0.05; right: ∗p < 0.05, ∗∗p < 0.01, Mann–Whitney U test).
Data are represented as mean ± SEM.
VIPP was selectively expressed in astrocytes. Venus fluorescence
was observed in 39% of hippocampal area CA1 GFAP positive
astrocytes (n= 527 out of 1343 from six animals; Figures 1C,D,I),
but was never detected in neurons (NeuN; Figures 1B,H), NG2-
glia (NG2; Figure 1E), oligodendrocytes (olig1; Figure 1F),
or microglia (Iba1; Figure 1G). In addition to hippocampal
VIPP expression, we also observed transgene expression in the
brainstem (Supplementary Figure S3A), and minimal expression
in the cortex. Double labeling with anti-NeuN never showed
transgene expression in neurons in any brain region.
We studied stimulus-induced astrocytic Ca2+ signaling in
the hippocampus, a brain region with prominent theta activity.
We found astrocytic Ca2+ was attenuated in slices derived
from VIPP mice. The time-integral of the Ca2+ response was
attenuated from a wild-type value of 2083 ± 360 1F/F0∗s to
156 ± 61 1F/F0∗s in astrocytes visually confirmed to express
VIPP (p < 0.0016, t-test) in response to exogenous application
of ATP (100 µM). Astrocytes with undetectable VIPP exhibited
Ca2+ signals that were not significantly different from wild-
type values (Figures 1J,K). Similarly, synaptic activity-dependent
recruitment of astrocytic Ca2+ signals was attenuated in VIPP
expressing astrocytes (Figures 1L–O). Ca2+ signals in VIPP
expressing astrocytes were attenuated from 3327 ± 940 1F/F0∗s
to 253 ± 70 1F/F0∗s (p < 0.025, t-test; Figures 1L,M)
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FIGURE 3 | Mice that overexpress IP3 5′-phosphatase in astrocytes
have increased REM sleep bouts. (A) Representative example of a
hypnogram from a wild type and (B) a VIPP mouse. (C) VIPP mice entered
REM sleep more frequently than wild type mice during the light phase.
(D) Wild type and VIPP mice had similar REM bout durations during the light
phase [values represent mean and standard error (SEM) for each group,
∗∗p < 0.01, Mann–Whitney U test].
following five trains of theta burst stimulation. The ability of
VIPP to attenuate astrocytic Ca2+ signals was not stimulus-
specific since the response to 100 Hz tetanic trains was also
significantly reduced in VIPP expressing astrocytes (p < 0.006,
t-test; Figures 1N,O).
VIPP Mice Exhibit Increased REM Sleep
To examine the importance of astrocytic IP3/Ca2+ signaling
in sleep regulation, we asked whether VIPP expression altered
the duration of each vigilance state. The percent time spent in
REM sleep was increased in VIPP expressing mice, compared
to wild type mice (Figure 2; VIPP, n = 12; WT, n = 8). This
was most apparent during the light phase (subjective nighttime),
and corresponded to an increase in number of REM bouts
(represented in Figures 3A,B and quantified in Figure 3C,
VIPP = 63.75 ± 1.6, wild type = 56.5 ± 2.0; p < 0.01).
However, REM bout duration was unchanged in VIPP mice
(Figure 3D). Mice spent significantly more time in REM sleep
during the second half of the light phase and the second half of
the dark phase (Figure 2C, ZT6-12; VIPP = 8.6 ± 0.4%, wild
type = 6.8 ± 0.3%; p < 0.01; ZT18-24; VIPP = 4.9 ± 0.4%, wild
type = 3.9 ± 0.4%; p < 0.05). During the second half of the light
phase, when VIPP mice spent a far greater percentage of time in
REM sleep, compared to wild type mice, they spent significantly
less time awake (Figure 2A, ZT6-12; VIPP = 34.5 ± 1.3%,
wild type = 39.8 ± 2.0%; p < 0.05). Throughout the light/dark
cycle, VIPP and wild type mice spent similar time in NREM
(Figure 2B). These data suggest that astrocyte IP3/Ca2+ signaling
specifically modulates the REM phase of sleep, particularly in the
later portion of the inactive period.
Astrocytic IP3/Ca2+ Signaling Modulates
REM But Not NREM Sleep Homeostasis
Astrocytes modulate plasticity and cortical oscillations as well as
sleep homeostasis (Fellin et al., 2009; Halassa et al., 2009; Lee
et al., 2014). Using genetically modified mice that have attenuated
gliotransmission, the dnSNARE mouse, it was shown that the
gliotransmitter adenosine (derived from ATP) is necessary for
the accumulation of sleep pressure (Halassa et al., 2009). Given
that Ca2+ signaling can contribute to gliotransmission (Porter
and McCarthy, 1997; Araque et al., 1998; Buzsàki, 2002; Hua
et al., 2004; Kreft et al., 2004; Chen et al., 2005; Pryazhnikov
and Khiroug, 2008; Paukert et al., 2014), we asked whether we
could reproduce the dnSNARE phenotype of impaired sleep
homeostasis by disrupting astrocytic IP3/Ca2+ signaling. We
compared baseline SWA and SWA following sleep deprivation in
VIPP and wild type littermate mice. VIPP mice neither exhibited
alterations in SWA (0.5–4 Hz) nor low frequency-SWA (lf-
SWA, 0.5–1.5 Hz) either in baseline conditions or following sleep
deprivation compared to wild type littermates (Supplementary
Figure S2) suggesting that IP3/Ca2+ signaling does not modulate
NREM sleep homeostasis.
The magnitude of the homeostatic increase in SWA delta
power that occurs with prolonged wake is positively correlated
with the duration of subsequent NREM sleep (McCarley, 2007).
REM sleep is also homeostatically regulated; REM-specific sleep
deprivation results in REM specific rebound sleep (Kitka et al.,
2009). However, the regulation of REM sleep homeostasis is
poorly understood. VIPP mice show enhanced REM rebound
sleep after 6 h of sleep deprivation, compared to wild type mice
(Figure 4). The greatest difference is seen in the later phase of
the light cycle, during ZT10-11 (Figure 4C; p< 0.05, Tukey’s post
hoc test). These data indicate that astrocyte IP3/Ca2+ signaling
modulates the homeostatic increase in REM sleep after SD.
VIPP Mice Exhibit Increased Theta Power
We next examined power spectra associated with each vigilance
state. We found enhanced EEG theta power in VIPP mice,
compared to wild type mice (Figure 5). This effect was present
during wakefulness, NREM and REM sleep. However, the most
robust effect occurred during REM sleep, where theta is the
dominant frequency in the power spectrum; although, theta is
also a prominent frequency in wakefulness during active stimulus
processing (Colgin, 2013). When a power analysis was performed
on the entire 24 h baseline day, VIPP mice exhibited enhanced
theta power (Figure 5A; WAKE: p < 0.05 at 7.1–8.1 Hz; NREM:
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FIGURE 4 | Enforced wake enhances REM rebound in VIPP mice to a
greater degree than wild type mice. (A) Representative example of a wild
type mouse hypnogram during (ZT0-6) and after SD (ZT6-24).
(B) Representative example of a VIPP mouse hypnogram during (ZT0-6) and
after SD (ZT6-24). (C) Percent time spent in REM sleep during the 6 h of sleep
deprivation and subsequent recovery period. VIPP mice spent significantly
more time in REM sleep during the recovery period compared to wild type
mice (ZT6-12: two-way RM ANOVA: ∗p < 0.05; ZT11: Tukey’s post hoc test:
∗p < 0.05). (D) Average percent recording time spent in REM sleep. VIPP
mice spend significantly more time in REM sleep after SD, compared to wild
type mice (ZT6-12: ∗p < 0.05, Mann–Whitney U test).
p < 0.05 at 3.6–4.1, 5.8–6.3 Hz; REM: p < 0.05 at 5.9–8.1 Hz).
When overall theta power (5–8 Hz) was averaged and compared
across genotypes, VIPP mice expressed significantly increased
power during REM sleep (p < 0.05; wild type: 3.6 ± 0.5; VIPP:
5.1± 0.4) but not during other vigilance states.
To assess a time-of-day effect on theta power, the baseline
day was broken down into the light and dark phase and power
spectra were analyzed for each vigilance state within these time
bins. In both the light and dark phase, average theta power was
significantly increased during REM sleep (Figures 5B,C). During
the light phase, VIPP mice exhibited enhanced power within
the theta frequency range across both NREM and REM sleep
(Figure 5B; WAKE: NS; NREM: p < 0.05 at 3.9–4.1, 5.3, 5.8–
6.3 Hz; REM: p < 0.05 at 5.4–8.1 Hz). When theta power was
averaged across the entire 5–8 Hz frequency range, an increase
in average theta power was observed in VIPP mice during REM
sleep only (inset: wild type: 3.5 ± 0.5; VIPP: 5.0 ± 0.4; p < 0.05).
During the dark phase, VIPP mice exhibited enhanced theta
power across all vigilance states (Figure 5C; WAKE: p < 0.05 at
7.1–8.1 Hz; NREM: p < 0.05 at 3.9 Hz; REM: p < 0.05 at 6.1–
8.1 Hz), but when averaged across frequencies, VIPP mice had
significantly greater theta power during REM sleep only (wild
type: 3.7± 0.6; VIPP: 5.8± 0.6; p< 0.05). These data suggest that
astrocyte IP3/Ca2+ signaling modulates theta power, especially
during REM sleep.
DISCUSSION
Gliotransmission and astrocytic Ca2+ signaling affect neuronal
activity in many ways (Araque et al., 2014). The present study
examined the behavioral effect of attenuated astrocytic IP3
dependent Ca2+ signaling throughout the brain. The major
conclusions from this study are that attenuated astrocytic
IP3/Ca2+ signaling leads to a modulation of REM sleep and
theta rhythm power. When this astrocytic signaling pathway
is impaired, mice spend more time in REM sleep due to an
increased frequency of REM bouts with no alteration in the
duration of individual events. Unique from the role of astrocyte
gliotransmission in NREM sleep homeostasis, impairment
of IP3/Ca2+ signaling in astrocytes does not attenuate the
homeostatic increase in lf-SWA after sleep deprivation. However,
since minimal transgene expression was found in the basal
forebrain and cortex in VIPP mice, these different observations
may result from a lack of VIPP expression in these regions
that are important in sleep homeostasis. Additionally, these
observations do not rule out potential contributions of other
Ca2+ sources including Ca2+ influx pathways in contributing to
gliotransmission in sleep homeostasis.
Mice with attenuated IP3/Ca2+ signaling specifically in
astrocytes spent more time in REM sleep than wild type mice
(Figure 2C). This was likely due to the fact that these VIPP
expressing mice entered REM sleep more frequently (Figure 3C).
VIPP mice had enhanced theta power, particularly during REM
sleep (Figure 5). These data suggest a role for astrocyte IP3/Ca2+
signaling in dampening theta power, perhaps via cholinergic
signaling in the hippocampus.
Our understanding of how cholinergic input modulates
neuronal and astrocytic function is incomplete (McQuiston,
2014). However, given that astrocytes respond to cholinergic
input in the hippocampus (Costa e Silva, 2006; Pabst et al.,
2016), future studies will determine whether the enhancement
of REM sleep and theta power in VIPP mice occurs through
cholinergic signaling in the hippocampus. The pons is of
particular importance in the generation of REM sleep and is also
a prominent source of cholinergic signaling. Future experiments
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FIGURE 5 | Astrocytic VIPP mice exhibit increased theta power compared to wild type mice. (A) EEG power over the entire 24-h recording period; inset
shows average theta (5–8 Hz) power. VIPP mice had increased theta power across all vigilance states (WAKE: two-way RM ANOVA: ∗p < 0.05; inset: n.s.; NREM:
two-way RM ANOVA: ∗p < 0.05; inset: n.s.; REM: two-way RM ANOVA: ∗p < 0.05; inset: Mann–Whitney U test, ∗p < 0.05). (B) Light cycle FFT data representation
of EEG power. Theta power is enhanced in VIPP mice during NREM and REM sleep (WAKE: two-way RM ANOVA: n.s.; inset: n.s.; NREM: two-way RM ANOVA:
∗p < 0.05; inset: n.s.; REM: two-way RM ANOVA: ∗p < 0.05; inset, Mann–Whitney U test: ∗p < 0.05). (C) Dark cycle FFT data representation of EEG power. Theta
power was enhanced in VIPP mice during WAKE, NREM, and REM. (WAKE: two-way RM ANOVA: ∗p < 0.05; inset: n.s.; NREM: two-way RM ANOVA: ∗p < 0.05;
inset: n.s.; REM: two-way RM ANOVA: ∗p < 0.05; inset, Mann–Whitney U test: ∗p < 0.05). Data are represented as mean ± SEM.
to assess brain region specific effects of the VIPP transgene in
response to cholinergic agonists will provide evidence of where
VIPP expression is required for a REM phenotype. Furthermore,
considering that theta power is most prominent during REM
sleep, testing a temporal effect of astrocyte Ca2+ perturbation
using targeted optogenetics may lead to a more mechanistic
understanding of astrocytic Ca2+ signaling in theta rhythm and
REM sleep regulation. Assuming the mechanism involves Ca2+
dependent exocytosis of gliotransmitter, the next goal will be to
determine which gliotransmitters regulate this pathway.
Our findings that attenuating IP3-dependent Ca2+ signaling
in astrocytes increases REM sleep and theta power conflict with
a previous report that knockout of the IP3R2 does not alter
sleep architecture in mice (Cao et al., 2013). The difference
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in results may be attributed to the inducible nature of our
genetic manipulation. In the Itpr2−/− mice used by Cao
et al. (2013), the IP3R2 is deleted throughout life, which may
allow for developmental adaptations to the absence of this
receptor. However, our method of inducible overexpression of
IPP allows for acute manipulation and analysis of astrocyte
mediated IP3Ca2+ signaling. Additionally, because we targeted
the metabolism of IP3 in our study it is possible that some of
the different results arise from differences in IP3 metabolism
between Itpr2−/− and VIPP mice. Although reasons for the
discrepancy in results using different mice remain uncertain,
because we found that several different parameters of REM
sleep were perturbed following VIPP expression we are confident
that astrocytic VIPP expression leads to REM phenotypes. For
example, we observed increased theta power during REM sleep,
an increase in time spent in REM sleep that results from an
increase in the number of bouts of REM sleep and finally we
observed that rebound REM sleep was enhanced following sleep
deprivation. Taken together, this is the first study to show that
in vivo manipulation of astrocyte IP3/Ca2+ signaling directly
affects sleep behavior.
We used the TetO system to induce VIPP expression in
astrocytes upon weaning. In this system, TetO is activated by
tTA (Figure 1A). Doxycycline (included in the diet) inhibits this
interaction and prevents transgene expression until doxycycline
is withdrawn from the diet. Doxycycline is known to exert
off-target effects (Ahler et al., 2013) in addition to regulating
transgene expression. Thus, all of our control comparisons were
made between wild type and transgenic animals in the same
doxycycline condition.
Recent publications challenge the validity of the TetO system
as a tool for astrocyte-specific expression (Fujita et al., 2014).
Fujita et al. (2014) report findings of neuronal expression in
dnSNARE mice, also driven by the TetO system, although
numerous other laboratories have been unable to reproduce
this anomaly. The reasons for this discrepancy are unclear
but may result from genetic drift of mice maintained in
different facilities and underscore the importance of repeated
characterization of lines of mice before making conclusions about
cell specificity. In our studies using the tetO.VIPP animals, we
have never observed neuronal expression. We see extremely
rare VIPP expression in the cortex and only in astrocytes,
never in neurons. We report abundant VIPP expression in the
brainstem (Supplementary Figure S3A). This expression does
not co-localize with the neuronal marker, NeuN (Supplementary
Figure S3B).
The homeostatic drive to sleep is characterized by increased
SWA power, or sleep pressure (McCarley, 2007). We have
previously shown that astrocyte gliotransmission contributes
to the accumulation of sleep pressure (Halassa et al., 2009).
Here, in contrast, we show that SWA sleep pressure is
unaltered in mice with attenuated astrocyte IP3/Ca2+ signaling
(Supplementary Figure S2). NREM sleep and delta power are
attenuated in dnSNARE mice, but remain intact in VIPP
mice, suggesting astrocyte SNARE-mediated gliotransmission
modulates sleep through a mechanism that is independent of
IP3/Ca2+ signaling. Furthermore, VIPP mice spend more time
in REM sleep and dnSNARE mice do not exhibit a REM
sleep phenotype (Halassa et al., 2009), suggesting IP3/Ca2+
signaling regulates REM sleep independently of SNARE-
mediated gliotransmission. These data suggest that there are
distinct astrocytic processes that regulate different aspects of
sleep and cortical function in general. Indeed, in a recent
study tetanus toxin disruption of vesicular mediated release
from astrocytes decreased gamma (25–80 Hz) frequency activity
(Lee et al., 2014). Taken together, these studies demonstrate
a previously unrecognized complexity to the signals that
astrocytes can utilize to modulate neuronal networks and rhythm
generation.
Mood disorders are associated with increased cholinergic
to aminergic neurotransmitter levels (Costa e Silva, 2006).
Accordingly, depressed individuals spend more time in REM
sleep (Steiger and Kimura, 2010). Treatment with antidepressants
decreases time spent in REM and discontinuation of medication
causes rebound REM sleep. Given that astrocytes respond to
cholinergic and aminergic stimulation by elevating intracellular
Ca2+ (Costa e Silva, 2006; Ding et al., 2013; Paukert et al., 2014),
and we found that mice with attenuated astrocytic IP3/Ca2+
signaling show increased REM sleep, further investigation of this
pathway may provide insight into the link between depression
and REM sleep.
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